Sources and Prices of Selected Drugs and Diagnostics for People Living with HIV/AIDS (UNAIDS, 2001, 36 p.): Annex I: Offers of donation/price reductions of antiretroviral drugs up to 15 April 2001

Sources and Prices of Selected Drugs and Diagnostics for People Living with HIV/AIDS (UNAIDS, 2001, 36 p.)

		(introduction...)
		Introduction
		Background
		Supply and prices
		Information on sources and prices of selected drugs and diagnostics
		Annex I: Offers of donation/price reductions of antiretroviral drugs up to 15 April 2001
		Annex II: Bulk procurement list for HIV tests
		Annex III: Manufacturers per therapeutic group included in the price survey (2000)
		Annex IV: Further information and contacts

Annex I: Offers of donation/price reductions of antiretroviral drugs up to 15 April 2001

(both offers made in response to the Expression of Interest launched in October 2000 and publicly announced offers)

Individual drug offers announced
Generic Name	Brand name *()**	Class	Unit dose ()**	Daily dose ()*		Manufacturer	Announced discount price/day (in US$)
Abacavir	Ziagen	NNRTI	300 mg	2 x 300 mg		GlaxoSmithKline	N/A
Abacavir		NNRTI	300 mg	2 x 300 mg		Hetero	10.64
Delavirdine	Rescriptor	NNRTI	100 mg	3 x 400 mg		Upjohn-Pharmacia	N/A
Didanosine (ddI)	Videx	NRTI	100 mg	4 x 100 mg		Bristol-Myers Squibb	0.85
Didanosine (ddI)		NRTI	100 mg	4 x 100 mg		Cipla	1.60
Didanosine (ddI)		NRTI	100 mg	4 x 100 mg		Aurobindo	0.52
Efavirenz	Stocrin/Sustiva	NNRTI	200 mg	3 x 200 mg		Merck/Dupont	1.37
Efavirenz	Stocrin/Sustiva	NNRTI	200 mg	3 x 200 mg		Merck/Dupont (for Brazil)	2.52
Efavirenz		NNRTI	200 mg	3 x 200 mg		Hetero	3.23
Efavirenz		NNRTI	200 mg	3 x 200 mg		Aurobindo	1.33
Indinavir	Crixivan	PI	400 mg	6 x 400 mg		Merck	1.64
Indinavir	Crixivan	PI	400 mg	6 x 400 mg		Merck (for Brazil)	2.82
Indinavir		PI	400 mg	6 x 400 mg		Hetero	6.30
Indinavir		PI	400 mg	6 x 400 mg		Cipla	5.04
Lamivudine (3TC)	Epivir	NRTI	150 mg	2 x 150 mg		GlaxoSmithKline	0.63
Lamivudine (3TC)		NRTI	150 mg	2 x 150 mg		Hetero	0.27
Lamivudine (3TC)	Lamivir	NRTI	150 mg	2 x 150 mg		Cipla (to not-for-profit programmes)	0.30
Lamivudine (3TC)		NRTI	150 mg	2 x 150 mg		Aurobindo	0.25
Nelfinavir	Viracept	PI	250 mg	9 x 250 mg		Roche	9.89¹
Nelfinavir		PI	250 mg	9 x 250 mg		Hetero	6.16
Nevirapine	Viramune	NNRTI	100 mg	2 x 200 mg		Boehringer Ingelheim	Free of charge for MTCT only 1.22 for adult treatment
Nevirapine		NNRTI	200 mg	2 x 200 mg		Hetero	0.55
Nevirapine	Nevimune	NNRTI	200 mg	2 x 200 mg		Cipla (to not-for-profit programmes)	0.54
						Cipla (for Uganda)	0.80
Ritonavir	Norvir	PI	600 mg	2 x 600 mg		Abbott	N/A
Ritonavir		PI	100 mg	12 x 100 mg		Hetero	11.78
Saquinavir softgel	Fortovase	PI	200 mg	9 x 200 mg		Roche	6.58²
Saquinavir softgel		PI	200 mg	9 x 200 mg		Hetero	2.72
Saquinavir hardgel	Invirase	PI	200 mg	9 x 200 mg		Roche	11.92
Saquinavir hardgel		PI	200 mg	9 x 200 mg		Aurobindo	6.78
Stavudine (d4T)	Zerit	NRTI	40 mg	2 x 40 mg		Bristol-Myers Squibb	0.15
Stavudine (d4T)		NRTI	50 mg	2 x 50 mg		Hetero	0.13
Stavudine (d4T)	Stavir	NRTI	40 mg	2 x 40 mg		Cipla (to not-for-profit programmes)	0.11
Stavudine (d4T)		NRTI	50 mg	2 x 40 mg		Aurobindo	0.13
Zalcitabine (ddC)	Hivid	NRTI	0.75 mg	3 x 0.75 mg		Roche	3.90
Zalcitabine (ddC)		NRTI	0.75 mg	3 x 0.75 mg		Hetero	0.12
Zidovudine (ZDV)	Retrovir	NRTI	250 mg	2 x 250 mg		GlaxoSmithKline	1.49
Zidovudine (ZDV)		NRTI	200 mg	2 x 200 mg		Hetero	0.53
Zidovudine (ZDV)	Zidovir	NRTI	300 mg	2 x 300 mg		Cipla	0.84
Zidovudine (ZDV)		NRTI	100 mg	6 x 100 mg		Aurobindo	0.50
Combination offers announced
Lamivudine, zidovudine and nevirapine		Generic triple therapy				Cipla (to not-for-profit programmes + Nigeria)	0.96
Lamivudine, zidovudine and nevirapine		Generic triple therapy				CIPLA offer to Governments	1.64
Lamivudine, zidovudine and nevirapine		Generic triple therapy				Aurobindo offer to Governments	0.81
Lamivudine, stavudine and nevirapine		Generic triple therapy				Hetero offer to Governments	0.95
Lamivudine+zidovudine (Combivir)		NRTI	150 mg + 300 mg	2 x 1 tab		GlaxoSmithKline (for developing countries)	2.00
Lamivudine+zidovudine (Duovir)		NRTI	150 mg + 300 mg	2 x 1 tab		CIPLA (for Uganda)	1.52
(*) Brand names may vary between countries					NNRTI = Non Nucleoside Reverse Transcriptase Inhibitors
(**) Other unit doses may exist					NRTI = Nucleoside Reverse Transcriptase Inhibitors
(***) Adult dose					PI = Protease Inhibitors

¹For each single pack purchased, one extra pack is delivered free of charge (for Sub-Saharan Africa only).
² For every 100 packs purchased, 15 extra packs delivered free of charge (for Sub-Saharan Africa only).